AZD5658
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AZD5658, covering 2012-02-02 to 2012-02-02. Get the full timeline:
Most recent: Clinical Trial Update: To Assess Safety, Tolerability, Pharmacokinetics/Pharmacodynamics and the Effect of Fasting After Single Oral Doses of AZD5658 in Type 2 Diabetes [Phase 1]